Viral therapeutics

Details Viral therapeutics Viral therapeutics

A - Human Necessities

61

K

A61K 38/16 (2006.01) A61K 31/70 (2006.01) A61K 38/08 (2006.01) A61K 38/10 (2006.01) A61K 48/00 (2006.01) C07K 14/18 (2006.01) C12Q 1/70 (2006.01) G01N 33/53 (2006.01) G01N 33/576 (2006.01) G01N 33/92 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2252966

An method for identifying a substance for affecting a viral infection is described. The method comprises: (a) providing a lipid globule targeting sequence, as a first component; (b) providing a lipid globule, as a second component; (c) contacting the two components with a substance to be tested under conditions that would permit the two components to interact in the absence of the substance; and (d) determining whether the substance disrupts the interaction between the first and second components; wherein the targeting sequence comprises a hepatitis C virus (HCV) core protein or a fragment, derivative, variant or homologue thereof.

Affiliated with

Also associated with

Rating

Viral therapeutics does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Viral therapeutics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Viral therapeutics will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1942002